Exercise-induced improvements in mitochondrial number and function help prevent the decline in metabolism that often follows rapid weight loss or calorie restriction
Therefore, the pharmacokinetic differences between linkers must be matched to specific clinical objectives
However, important safety considerations include: Avoid use if you or your family have a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2)
A more gradual approach may be recommended if you: Have experienced nausea with GLP-1 medications before Are sensitive to appetite suppressants Have a history of digestive issues Prefer a gentler adjustment period In these cases, remaining on the starting dose longer, or increasing in smaller steps, can significantly improve comfort
Starting GLP-1 medications prematurely can cause increased nausea and vomiting, delayed gastric emptying, compromised nutritional intake, dehydration, and potentially delayed wound healing
And while its true that GLP-1 drugs have proven benefits for some people, not all GLP-1 medications are the same
